References

Araujo, A., Julious, S., & Senn, S. (2016). Understanding variation in sets of N-of-1 trials. PLOS ONE, 11(12), e0167167.

Ard, M. C., & Edland, S. D. (2011). Design and analysis considerations in alzheimer disease clinical trials. Clinical Investigation, 1(8), 1091–1098.

Armitage, P. (1955). Tests for linear trends in proportions and frequencies. Biometrics, 11(3), 375–386.

Armitage, P., McPherson, C. K., & Rowe, B. C. (1969). Repeated significance tests on accumulating data. Journal of the Royal Statistical Society: Series A, 132(2), 235–244.

Asakura, K., Evans, S. R., & Hamasaki, T. (2020). Interim monitoring for futility in clinical trials with two co-primary endpoints using prediction. Statistics in Biopharmaceutical Research.

Azher, R. A., Wason, J. M. S., & Grayling, M. J. (2024). A comparison of randomization methods for multi-arm clinical trials. Statistics in Medicine.

Babb, J., Rogatko, A., & Zacks, S. (1998). Cancer phase I clinical trials: Efficient dose escalation with overdose control. Statistics in Medicine, 17(10), 1103–1120.

Barnard, G. A. (1947). Significance tests for 2 × 2 tables. Biometrika, 34(1/2), 123–138.

Berger, V. W., Rezvani, A., & Makarewicz, V. A. (2003). Direct effect on validity of response run-in selection in clinical trials. Controlled Clinical Trials, 24(2), 156–166.

Berry, S. M., Carlin, B. P., Lee, J. J., & Müller, P. (2010). Bayesian adaptive methods for clinical trials. Chapman; Hall/CRC.

Boschloo, R. D. (1970). Raised conditional level of significance for the 2 × 2-table when testing the equality of two probabilities. Statistica Neerlandica, 24(1), 1–9.

Bugni, F. A., Canay, I. A., & Shaikh, A. M. (2018). Inference under covariate-adaptive randomization. Journal of the American Statistical Association, 113(524), 1784–1796.

Buuren, S. van, & Groothuis-Oudshoorn, K. (2011). mice: Multivariate imputation by chained equations in R. Journal of Statistical Software, 45(3), 1–67.

Callegaro, A., Shree, B. S. H., & Karkada, N. (2021). Inference under covariate-adaptive randomization: A simulation study. Statistical Methods in Medical Research, 30(5), 1273–1284.

Candel, M. J. J. M., & Van Breukelen, G. J. P. (2023). Best (but oft forgotten) practices: Efficient sample sizes for commonly used trial designs. American Journal of Clinical Nutrition.

Carpenter, J. R., Roger, J. H., & Kenward, M. G. (2013). Analysis of longitudinal trials with protocol deviation: A framework for relevant, accessible assumptions, and inference via multiple imputation. Journal of Biopharmaceutical Statistics, 23(6), 1352–1371.

Chan, A.-W., Tetzlaff, J. M., Altman, D. G., et al. (2013). SPIRIT 2013 statement: Defining standard protocol items for clinical trials. Annals of Internal Medicine, 158(3), 200–207.

Cheung, Y. K. (2011). Dose finding by the continual reassessment method. Chapman; Hall/CRC.

Chow, S.-C., & Chang, M. (2008). Adaptive design methods in clinical trials: A review. Orphanet Journal of Rare Diseases, 3, 11.

Coart, E., Bamps, P., Quinaux, E., Sturbois, G., Saad, E. D., Burzykowski, T., & Buyse, M. (2023). Minimization in randomized clinical trials. Statistics in Medicine.

Cochran, W. G. (1954). Some methods for strengthening the common χ² tests. Biometrics, 10(4), 417–451.

Crans, G. G., & Shuster, J. J. (2008). How conservative is Fisher’s exact test? A quantitative evaluation of the two-sample comparative binomial trial. Statistics in Medicine, 27(18), 3598–3611.

De Silva, A. P., Moreno-Betancur, M., De Livera, A. M., Lee, K. J., & Simpson, J. A. (2017). A comparison of multiple imputation methods for handling missing values in longitudinal data in the presence of a time-varying covariate with a non-linear association with time. BMC Medical Research Methodology, 17.

Diggle, P. J., Heagerty, P., Liang, K.-Y., & Zeger, S. L. (2002). Analysis of longitudinal data. Oxford Statistical Science Series.

Diggle, P., & Kenward, M. G. (1994). Informative drop-out in longitudinal data analysis. Journal of the Royal Statistical Society: Series C, 43(1), 49–93.

Dmitrienko, A., Tamhane, A. C., & Bretz, F. (2009). Multiple testing problems in pharmaceutical statistics. Chapman; Hall/CRC.

Donohue, M. C., Jacqmin-Gadda, H., Le Goff, M., et al. (2014). Estimating long-term multivariate progression from short-term data. Alzheimer’s and Dementia, 10(5), S400–S410.

Duan, N., Kravitz, R. L., & Schmid, C. H. (2013). Single-patient (N-of-1) trials: A pragmatic clinical decision methodology for patient-centered comparative effectiveness research. Journal of Clinical Epidemiology, 66(8), S21–S28.

Edwards, L. J., Muller, K. E., Wolfinger, R. D., Qaqish, B. F., & Schabenberger, O. (2008). An R² statistic for fixed effects in the linear mixed model. Statistics in Medicine, 27(29), 6137–6157.

Efron, B. (1971). Forcing a sequential experiment to be balanced. Biometrika, 58(3), 403–417.

Ellenberg, S. S., Fleming, T. R., & DeMets, D. L. (2019). Data monitoring committees in clinical trials: A practical perspective (2nd ed.). Wiley.

European Medicines Agency. (2019). Guideline on the investigation of subgroups in confirmatory clinical trials. EMA.

Fay, M. P., & Hunsberger, S. A. (2021). Practical valid inferences for the two-sample binomial problem. Statistics Surveys, 15, 72–110.

Feaster, D. J., Mikulich-Gilbertson, S., & Brincks, A. M. (2011). Modeling site effects in the design and analysis of multi-site trials. American Journal of Drug and Alcohol Abuse, 37(5), 383–391.

Fitzmaurice, G. M., Laird, N. M., & Ware, J. H. (2011). Applied longitudinal analysis (2nd ed.). Wiley.

Fleming, T. R., & Harrington, D. P. (1991). Counting processes and survival analysis. Wiley.

Freedman, D. A. (2008). On regression adjustments to experimental data. Advances in Applied Mathematics, 40(2), 180–193.

Friede, T., & Kieser, M. (2006). Sample size recalculation in internal pilot study designs: A review. Biometrical Journal, 48(4), 537–555.

Friedman, L. M., Furberg, C. D., DeMets, D. L., Reboussin, D. M., & Granger, C. B. (2015). Fundamentals of clinical trials (5th ed.). Springer.

Frost, C., Kenward, M. G., & Fox, N. C. (2008). Optimizing the design of clinical trials where the outcome is a rate: Can estimating a baseline rate in a run-in period increase efficiency? Statistics in Medicine, 27(19), 3717–3731.

Greevy, R., Lu, B., Silber, J. H., & Rosenbaum, P. (2004). Optimal multivariate matching before randomization. Biostatistics, 5(2), 263–275.

Halperin, M., Lan, K. K. G., Ware, J. H., Johnson, N. J., & DeMets, D. L. (1982). An aid to data monitoring in long-term clinical trials. Controlled Clinical Trials, 3(4), 311–323.

Harrall, K. K., Muller, K. E., Starling, A. P., Adgate, J. L., Dabelea, D., & Magzamen, S. (2023). Power and sample size analysis for longitudinal mixed models of health in populations exposed to environmental contaminants: A tutorial. BMC Medical Research Methodology, 23.

Hayes, R. J., & Moulton, L. H. (2017). Cluster randomised trials (2nd ed.). Chapman; Hall/CRC.

Hendrickson, R. C., Thomas, R. G., Schork, N. J., & Raskind, M. A. (2020). Optimizing aggregated N-of-1 trial designs for predictive biomarker validation: Statistical methods and theoretical findings. Frontiers in Digital Health, 2.

Hilgers, R.-D., Manolov, M., Heussen, N., & Rosenberger, W. F. (2020). Design and analysis of stratified clinical trials in the presence of bias. Statistical Methods in Medical Research, 29(6), 1715–1727.

Hochberg, Y., & Tamhane, A. C. (1987). Multiple comparison procedures. Wiley.

Huque, M. H., Carlin, J. B., Simpson, J. A., & Lee, K. J. (2018). A comparison of multiple imputation methods for missing data in longitudinal studies. BMC Medical Research Methodology, 18.

Hussey, M. A., & Hughes, J. P. (2007). Design and analysis of stepped wedge cluster randomized trials. Contemporary Clinical Trials, 28(2), 182–191.

Iddi, S., & Donohue, M. C. (2022). Power and sample size for longitudinal models in R: The longpower package and Shiny app. The R Journal, 14(1), 264–282.

International Council for Harmonisation. (2019). ICH E9(R1) addendum on estimands and sensitivity analysis in clinical trials. ICH Harmonised Guideline.

Jennison, C., & Turnbull, B. W. (2000). Group sequential methods with applications to clinical trials. Chapman; Hall/CRC.

Kahan, B. C., Jairath, V., Doré, C. J., & Morris, T. P. (2014). The risks and rewards of covariate adjustment in randomized trials: An assessment of 12 outcomes from 8 studies. Trials, 15, 139.

Kahan, B. C., & Morris, T. P. (2012). Improper analysis of trials randomised using stratified blocks or minimisation. Statistics in Medicine, 31(4), 328–340.

Kim, J., Troxel, A. B., Halpern, S. D., Volpp, K. G., Kahan, B. C., Morris, T. P., & Harhay, M. O. (2020). Analysis of multicenter clinical trials with very low event rates. Trials, 21.

Kravitz, R. L., Duan, N., & Braslow, J. (2004). Evidence-based medicine, heterogeneity of treatment effects, and the trouble with averages. Milbank Quarterly, 82(4), 661–687.

Lachin, J. M. (1981). Introduction to sample size determination and power analysis for clinical trials. Controlled Clinical Trials, 2(2), 93–113.

Lachin, J. M. (1988). Properties of simple randomization in clinical trials. Controlled Clinical Trials, 9(4), 312–326.

Laird, N. M., & Wang, F. (1990). Estimating rates of change in randomized clinical trials. Controlled Clinical Trials, 11(6), 405–419.

Lan, K. K. G., & DeMets, D. L. (1983). Discrete sequential boundaries for clinical trials. Biometrika, 70(3), 659–663.

Lan, K. K. G., Simon, R., & Halperin, M. (1982). Stochastically curtailed tests in long-term clinical trials. Communications in Statistics: Sequential Analysis, 1(3), 207–219.

Lin, W. (2013). Agnostic notes on regression adjustments to experimental data: Reexamining freedman’s critique. Annals of Applied Statistics, 7(1), 295–318.

Lipkovich, I., Ratitch, B., & Mallinckrodt, C. H. (2020). Causal inference and estimands in clinical trials. Statistics in Biopharmaceutical Research, 12(1), 54–67.

Little, R. J. A., & Rubin, D. B. (2019). Statistical analysis with missing data (3rd ed.). Wiley.

Liu, S., & Yuan, Y. (2015). Bayesian optimal interval designs for phase I clinical trials. Journal of the Royal Statistical Society: Series C, 64(3), 507–523.

Localio, A. R., Berlin, J. A., Ten Have, T. R., & Kimmel, S. E. (2001). Adjustments for center in multicenter studies: An overview. Annals of Internal Medicine, 135(2), 112–123.

Lydersen, S., & Laake, P. (2003). Power comparison of two-sided exact tests for association in 2 × 2 contingency tables using standard, mid-p and randomized test versions. Statistics in Medicine, 22(24), 3859–3871.

Mallinckrodt, C. H., Lane, P. W., Schnell, D., Peng, Y., & Mancuso, J. P. (2008). Recommendations for the primary analysis of continuous endpoints in longitudinal clinical trials. Drug Information Journal, 42(4), 303–319.

Mehrotra, D. V., Chan, I. S. F., & Berger, R. L. (2003). A cautionary note on exact unconditional inference for a difference between two independent binomial proportions. Biometrics, 59(2), 441–450.

Mehta, C. R., & Patel, N. R. (1983). A network algorithm for performing fisher’s exact test in r × c contingency tables. Journal of the American Statistical Association, 78(382), 427–434.

Mehta, C. R., & Pocock, S. J. (2011). Adaptive increase in sample size when interim results are promising: A practical guide with examples. Statistics in Medicine, 30(28), 3267–3284.

Molenberghs, G., & Kenward, M. G. (2007). Missing data in clinical studies. Wiley.

Moore, K. L., & Laan, M. J. van der. (2009). Covariate adjustment in randomized trials with binary outcomes: Targeted maximum likelihood estimation. Statistics in Medicine, 28(1), 39–64.

Nakagawa, S., & Schielzeth, H. (2013). A general and simple method for obtaining R² from generalized linear mixed-effects models. Methods in Ecology and Evolution, 4(2), 133–142.

National Research Council. (2010). The prevention and treatment of missing data in clinical trials. National Academies Press.

O’Brien, P. C., & Fleming, T. R. (1979). A multiple testing procedure for clinical trials. Biometrics, 35(3), 549–556.

O’Quigley, J., Pepe, M., & Fisher, L. (1990). Continual reassessment method: A practical design for phase 1 clinical trials in cancer. Biometrics, 46(1), 33–48.

Ouwens, M. J. N. M., Tan, F. E. S., & Berger, M. P. F. (2002). Maximin D-optimal designs for longitudinal mixed effects models. Biometrics, 58(4), 735–741.

Overall, J. E., Tonidandel, S., & Starbuck, R. R. (2006). Rule-of-thumb adjustment of sample sizes to accommodate dropouts in a two-stage analysis of repeated measurements. International Journal of Methods in Psychiatric Research, 15(1), 1–11.

Pablos-Mendez, A., Barr, R. G., & Shea, S. (1998). The use of run-in periods in randomized trials. JAMA, 279(3), 222–225.

Piantadosi, S. (2017). Clinical trials: A methodologic perspective (3rd ed.). Wiley.

Pocock, S. J. (1976). The combination of randomized and historical controls in clinical trials. Journal of Chronic Diseases, 29(3), 175–188.

Pocock, S. J. (1977). Group sequential methods in the design and analysis of clinical trials. Biometrika, 64(2), 191–199.

Pocock, S. J., Assmann, S. E., Enos, L. E., & Kasten, L. E. (2002). Subgroup analysis, covariate adjustment and baseline comparisons in clinical trial reporting. Statistics in Medicine, 21(19), 2917–2930.

Pocock, S. J., & Simon, R. (1975). Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial. Biometrics, 31(1), 103–115.

Proschan, M. A. (2005). Two-stage sample size re-estimation based on a nuisance parameter: A review. Journal of Biopharmaceutical Statistics, 15(4), 559–574.

Raab, G. M., Day, S., & Sales, J. (2000). How to select covariates to include in the analysis of a clinical trial. Controlled Clinical Trials, 21(4), 330–342.

Rosenberger, W. F., & Lachin, J. M. (2016). Randomization in clinical trials: Theory and practice (2nd ed.). Wiley.

Schmid, C. H., & Staudenmayer, J. (2021). Bayesian models for N-of-1 trials. Harvard Data Science Review.

Schork, N. J. (2015). Personalized medicine: Time for one-person trials. Nature, 520(7549), 609–611.

Schulz, K. F., Altman, D. G., & Moher, D. (2010). CONSORT 2010 statement: Updated guidelines for reporting parallel group randomised trials. BMJ, 340, c332.

Senn, S. (1994). Testing for baseline balance in clinical trials. Statistics in Medicine, 13(17), 1715–1726.

Senn, S. (2002). Cross-over trials in clinical research (2nd ed.). Wiley.

Senn, S. (2007). Statistical issues in drug development (2nd ed.). Wiley.

Senn, S. (2019). Sample size considerations for n-of-1 trials. Statistical Methods in Medical Research, 28(2), 372–383.

Senn, S., & Julious, S. (2024). The analysis of continuous data from n-of-1 trials using paired cycles: A simple tutorial. Trials, 25.

Shan, G., Li, Y., Lu, X., Zhang, Y., & Wu, S. S. (2024). Comparison of Pocock and Simon’s covariate-adaptive randomization procedures in clinical trials. BMC Medical Research Methodology, 24.

Shao, J., Yu, X., & Zhong, B. (2010). A theory for testing hypotheses under covariate-adaptive randomization. Biometrika, 97(2), 347–360.

Simon, R. (1989). Optimal two-stage designs for phase II clinical trials. Controlled Clinical Trials, 10(1), 1–10.

Stekhoven, D. J., & Bühlmann, P. (2012). MissForest: Non-parametric missing value imputation for mixed-type data. Bioinformatics, 28(1), 112–118.

Suissa, S., & Shuster, J. J. (1985). Exact unconditional sample sizes for the 2 × 2 binomial trial. Journal of the Royal Statistical Society: Series A, 148(4), 317–327.

Sverdlov, O., Ryeznik, Y., Anisimov, V., Kuznetsova, O. M., Knight, R., Carter, K., Drescher, S., & Zhao, W. (2024). Selecting a randomization method for a multi-center clinical trial with stochastic recruitment considerations. BMC Medical Research Methodology.

Taves, D. R. (2010). The use of minimization in clinical trials. Contemporary Clinical Trials, 31(2), 180–184.

Tsiatis, A. A., Davidian, M., Zhang, M., & Lu, X. (2008). Covariate adjustment for two-sample treatment comparisons in randomized clinical trials: A principled yet flexible approach. Statistics in Medicine, 27(23), 4658–4677.

US Food and Drug Administration. (2019). Adaptive designs for clinical trials of drugs and biologics: Guidance for industry. FDA.

US Food and Drug Administration. (2021). Adjusting for covariates in randomized clinical trials for drugs and biological products: Guidance for industry. FDA.

Van Lancker, K., Bretz, F., & Dukes, O. (2024). Covariate adjustment in randomized controlled trials: General concepts and practical considerations. Clinical Trials.

Vohra, S., Shamseer, L., Sampson, M., et al. (2015). CONSORT extension for reporting N-of-1 trials (CENT) 2015 statement. BMJ, 350, h1738.

Wald, A. (1945). Sequential tests of statistical hypotheses. Annals of Mathematical Statistics, 16(2), 117–186.

Wang, B., Ogburn, E. L., & Rosenblum, M. (2019). Analysis of covariance in randomized trials: More precision and valid confidence intervals, without model assumptions. Biometrics, 75(4), 1391–1400.

Wang, Y., Rosenberger, W. F., & Uschner, D. (2020). Randomization tests for multiarmed randomized clinical trials. Statistics in Medicine.

Whitehead, J. (1997). The design and analysis of sequential clinical trials (2nd ed.). Wiley.

Winkens, B., Schouten, H. J. A., Breukelen, G. J. P. van, & Berger, M. P. F. (2005). Optimal time-points in clinical trials with linearly divergent treatment effects. Statistics in Medicine, 24(24), 3743–3756.

Winkens, B., Schouten, H. J. A., Breukelen, G. J. P. van, & Berger, M. P. F. (2006). Optimal number of repeated measures and group sizes in clinical trials with linearly divergent treatment effects. Contemporary Clinical Trials, 27(1), 57–69.

Ye, T., Shao, J., Yi, Y., & Zhao, Q. (2023). Toward better practice of covariate adjustment in analyzing randomized clinical trials. Journal of the American Statistical Association.

Yusuf, S., Collins, R., & Peto, R. (1991). Factorial designs in clinical trials. Statistics in Medicine, 10(6), 867–878.

Zhao, Y., & Edland, S. D. (2022). Power formulas for mixed effects models with random slope and intercept comparing rate of change across groups. Biometrical Journal.

Zucker, D. R., Ruthazer, R., & Schmid, C. H. (2010). Individual (N-of-1) trials can be combined to give population comparative treatment effect estimates: Methodologic considerations. Journal of Clinical Epidemiology, 63(12), 1312–1323.